Drug major Lupin posted consolidated net profit of Rs.547 crore for the quarter ended March 31, 2015 compared to Rs.553 crore posted during the corresponding quarter a year back.
In a filing in the Bombay Stock Exchange, the company said the consolidated net profit dropped one percent during the fourth quarter of 2014-15.
It attributed the fall in profit to higher price erosion in the US as well as a slowdown in product approvals impacted growth in the quarter.
The total income of the company for the period under review has decreased from Rs.3,125.73 crore for the quarter ended March 31, 2014 to Rs.3,095.35 crore for the quarter ended March 31, 2015.
